Lingji Guo

581 total citations
17 papers, 437 citations indexed

About

Lingji Guo is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Lingji Guo has authored 17 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Lingji Guo's work include Thyroid Cancer Diagnosis and Treatment (5 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Lingji Guo is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (5 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Lingji Guo collaborates with scholars based in China and United States. Lingji Guo's co-authors include Bo Gao, Wuguo Tian, Shuai Hao, Jianjie Zhao, Yongkui Shan, Qinghai Cai, Bin Lü, Donglin Luo, Yan Jiang and Shu Zhang and has published in prestigious journals such as Medicine, Journal of Cellular Biochemistry and Human Pathology.

In The Last Decade

Lingji Guo

17 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingji Guo China	13	207	185	77	75	52	17	437
Charles J. Murphy United States	14	311 1.5×	84 0.5×	7 0.1×	19 0.3×	148 2.8×	26	723
Shenglin Xu China	12	101 0.5×	64 0.3×	9 0.1×	4 0.1×	26 0.5×	25	343
Yoichi Hoshino Japan	11	304 1.5×	65 0.4×	11 0.1×	11 0.1×	71 1.4×	35	534
Yuki Miyahara Japan	13	151 0.7×	17 0.1×	61 0.8×	7 0.1×	80 1.5×	39	376
Kimihiro Suzuki Japan	14	107 0.5×	33 0.2×	16 0.2×	18 0.2×	22 0.4×	53	502
Miguel A. Ramos Japan	8	228 1.1×	130 0.7×	3 0.0×	14 0.2×	36 0.7×	15	538
Jiahong Jiang China	15	451 2.2×	372 2.0×	4 0.1×	19 0.3×	159 3.1×	36	737
Hyemin Jeong South Korea	11	41 0.2×	19 0.1×	46 0.6×	55 0.7×	24 0.5×	24	364
Zhen Yu China	13	148 0.7×	64 0.3×	3 0.0×	26 0.3×	54 1.0×	35	453
Katsuhiro Ono Japan	14	461 2.2×	86 0.5×	8 0.1×	8 0.1×	394 7.6×	25	780

Countries citing papers authored by Lingji Guo

Since Specialization

Citations

This map shows the geographic impact of Lingji Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingji Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingji Guo more than expected).

Fields of papers citing papers by Lingji Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingji Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingji Guo. The network helps show where Lingji Guo may publish in the future.

Co-authorship network of co-authors of Lingji Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Lingji Guo. A scholar is included among the top collaborators of Lingji Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingji Guo. Lingji Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Huang, Qi, Yujun He, Xiaohua Zhang, & Lingji Guo. (2021). Circular RNA hsa_circ_0103552 Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells through Upregulating Cysteine-Rich Angiogenic Inducer 61 (CYR61) Expression via Sponging MicroRNA-515-5p. The Tohoku Journal of Experimental Medicine. 255(2). 171–181. 14 indexed citations

Huang, Qi, Xiaohua Zhang, Lingji Guo, & Yujun He. (2019). Surgery on primary melanoma of the breast. Translational Cancer Research. 8(S5). S463–S468. 2 indexed citations

Tian, Wuguo, Shuai Hao, Bo Gao, et al.. (2018). Lobaplatin inhibits breast cancer progression, cell proliferation while induces cell apoptosis by downregulating MTDH expression. Drug Design Development and Therapy. Volume 12. 3563–3571. 13 indexed citations

Gao, Bo, Lingji Guo, Donglin Luo, et al.. (2018). Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer. Bioscience Reports. 38(3). 16 indexed citations

Guo, Lingji, Shu Zhang, Bo Gao, et al.. (2017). Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer. Experimental and Molecular Pathology. 102(3). 500–504. 35 indexed citations

Jiang, Yan, Shuai Hao, Wuguo Tian, et al.. (2017). PI3K inhibitors IC87114 inhibits the migration and invasion of thyroid cancer cell in vitro and in vivo. Journal of Cellular Biochemistry. 119(5). 4097–4102. 4 indexed citations

Hao, Shuai, Wuguo Tian, Bo Gao, et al.. (2017). Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials. Oncotarget. 8(12). 19923–19933. 6 indexed citations

Zhang, Shu, Lingji Guo, Gang Zhang, et al.. (2016). Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus. Tumor Biology. 37(8). 11057–11063. 20 indexed citations

Tian, Wuguo, Shuai Hao, Bo Gao, et al.. (2016). Comparing the Diagnostic Accuracy of RTE and SWE in Differentiating Malignant Thyroid Nodules from Benign Ones: a Meta-Analysis. Cellular Physiology and Biochemistry. 39(6). 2451–2463. 31 indexed citations

10.

Wang, Lingli, Shuai Hao, Shu Zhang, et al.. (2016). PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases. Human Pathology. 61. 49–57. 32 indexed citations

11.

Zhao, Jianjie, Shuai Hao, Lingli Wang, et al.. (2016). Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway. Oncotarget. 7(36). 57903–57918. 96 indexed citations

12.

Gao, Bo, Shuai Hao, Wuguo Tian, et al.. (2016). MicroRNA‐107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain‐derived neurotrophic factor. The Journal of Gene Medicine. 19(12). 29 indexed citations

13.

Zhang, Xiaohua, Shuai Hao, Bo Gao, et al.. (2016). A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer. Oncotarget. 7(51). 84533–84543. 12 indexed citations

14.

Tian, Wuguo, Shuai Hao, Bo Gao, et al.. (2015). Comparison of Diagnostic Accuracy of Real-Time Elastography and Shear Wave Elastography in Differentiation Malignant From Benign Thyroid Nodules. Medicine. 94(52). e2312–e2312. 32 indexed citations

15.

Gao, Bo, Wuguo Tian, Yan Jiang, et al.. (2015). Application of carbon nanoparticles for parathyroid protection in reoperation of thyroid diseases.. PubMed. 8(12). 22254–61. 13 indexed citations

16.

Gao, Bo, Yan Jiang, Shu Zhang, et al.. (2015). Surgical diagnosis and treatment of primary hyperparathyroidism: analysis of 19 cases.. PubMed. 8(6). 9512–8. 1 indexed citations

17.

Cai, Qinghai, Bin Lü, Lingji Guo, & Yongkui Shan. (2008). Studies on synthesis of dimethyl carbonate from methanol and carbon dioxide. Catalysis Communications. 10(5). 605–609. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact